TNFSF10 and breast carcinoma: Furthermore, endogenous, tumor cell-derived TRAIL may lead to a constitutive endocytosis of the death receptors and, consequently, to a lower expression of these receptors at the cell surface as has been demonstrated i.e. for breast cancer cells [31].